Mutations in RPE65 cause Leber's congenital amaurosis
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, human RPE65 mutations were shown to cause Leber Congenital Amaurosis (LCA), a recessive, severe childhood blinding disease.440,441”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [440]
Citations
Cites
Mullen, R. J., & LaVail, M. M. (1976) · Science · doi:10.1126/science.1265483 · Cited by 527
Retinal–specific guanylate cyclase gene mutations in Leber's congenital amaurosis
Perrault, I., Rozet, J. M., Calvas, P., Gerber, S., Camuzat, A., Dollfus, H., Châtelin, S., Souied, E., Ghazi, I., Leowski, C., et al. (1996) · Nature Genetics · doi:10.1038/ng1296-461 · Cited by 445
Hamel, C. P., Tsilou, E., Pfeffer, B. A., Hooks, J. J., Detrick, B., & Redmond, T. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82319-5 · Cited by 334
Self-citationClassification of Congenital and Early Onset Retinitis Pigmentosa
Foxman, S. G., Heckenlively, J. R., Bateman, J. B., & Wirtschafter, J. D. (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050100078023 · Cited by 158
Hamel, C. P., Tsilou, E., Harris, E., Pfeffer, B. A., Hooks, J. J., Detrick, B., & Redmond, T. M. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340406 · Cited by 117
Self-citationLi, T., & Davidson, B. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7700 · Cited by 97
Inherited retinal degeneration: exceptional genetic and clinical heterogeneity
Sullivan, L. S., & Daiger, S. P. (1996) · Molecular Medicine Today · doi:10.1016/s1357-4310(96)10037-x · Cited by 75
Hamel, C., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., & Redmond, T. M. (1994) · Genomics · doi:10.1006/geno.1994.1212 · Cited by 66
Self-citationA gene for Leber's congenital amaurosis maps to chromosome 17p
Camuzat, A., Dollfus, H., Rozet, J., Gerber, S., Bonneau, D., Bonnemaison, M., Briard, M., Dufier, J., Ghazi, I., Leowski, C., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1447 · Cited by 61
(1869) · Scientific American · doi:10.1038/scientificamerican01011869-13 · Cited by 2
Research works printed but not linked: 2
- Crouch, R.K., Goletz, P., Yu, S. & Redmond, T.M., Invest. Ophthalmol. Vis. Sci. 38, S304 (1997).
- Redmond, T.M. et al. Invest. Ophthalmol. Vis. Sci. 36, s598 (1995).
Cited by
Items 401–500 of 613
Nonadrenergic innervation of the rat laryngeal vasculature
Lyon, M. J. (2000) · The Anatomical Record · doi:10.1002/(sici)1097-0185(20000601)259:2<124::aid-ar2>3.0.co;2-o · Cited by 7
A Gene Scan Study of RPE65 in Chinese Patients with Leber Congenital Amaurosis
Liu, J., & Bu, J. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.218007 · Cited by 16
“[8,9] Missense mutations in RPE65 were identified in a patient with LCA2 using the candidate gene scanning approach.[10] Since the initial report, a wide range of RPE65 mutations associated with LCA had been identified.”
Advances and therapeutic opportunities in visual cycle modulation
Zaluski, J., Bassetto, M., Kiser, P. D., & Tochtrop, G. P. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101360 · Cited by 15
“For example, loss-of-function mutations in LRAT (Thompson et al., 2001) and RPE65 (Gu et al., 1997; Marlhens et al., 1997) cause a severe childhood blinding disease known as Leber congenital amaurosis in which extreme visual chromophore deficiency dramatically impairs visual function and results in…”
Ripamonti, C., Henning, G. B., Robbie, S. J., Sundaram, V., van den Born, L. I., Casteels, I., de Ravel, T. J. L., Moore, A. T., Smith, A. J., Bainbridge, J. W., et al. (2015) · Journal of Vision · doi:10.1167/15.15.20 · Cited by 16
“One form of the disease, LCA2, is caused by mutations in the RPE65 gene that encodes RPE65, a retinal pigment epithelium–specific 65-kDa isomerase (Gu et al., 1997; Lotery et al., 2000; Marlhens et al., 1997; Perrault, Rozet, Ghazi et al., 1999; Thompson et al., 2000).”
BackgroundThe Rpe65 rd12 Allele Exerts a Semidominant Negative Effect on Vision in Mice
Wright, C. B., Chrenek, M. A., Feng, W., Getz, S. E., Duncan, T. E., Pardue, M. T., Feng, Y., Redmond, T. M., Boatright, J. H., & Nickerson, J. M. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13574 · Cited by 17
Self-citationComparison of Ocular Pathologies in Vitamin A–Deficient Mice and RPE65 Gene Knockout Mice
Hu, Y., Chen, Y., Moiseyev, G. P., Takahashi, Y., Mott, R., & Ma, J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-7118 · Cited by 17
Stiles, M. A., Moiseyev, G. P., Budda, M. L., Linens, A., Brush, R. S., Qi, H., White, G. L., Wolf, R. F., Ma, J., Floyd, R. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145305 · Cited by 16
Expression and promoter activation of the Rpe65 gene in retinal pigment epithelium cell lines
Boulanger, A., & Redmond, T. M. (2002) · Current Eye Research · doi:10.1076/ceyr.24.5.368.8523 · Cited by 17
Self-citationJoseph, B., Srinivasan, A., Soumittra, N., Vidhya, A., Shetty, N. S., Uthra, S., & Kumaramanickavel, G. (2002) · Journal of Genetics · doi:10.1007/bf02715866 · Cited by 16
“Marlhens et al. (1997) studied 12 patients with LCA and reported mutations in RPE65.”
BackgroundDevelopmental eye disease - a genome era paradigm
van Heyningen, V., & McInnes, R. R. (1998) · Clinical Genetics · doi:10.1034/j.1399-0004.1998.5440403.x · Cited by 15
The versatile roles of retinal pigment epithelium in the pathophysiology of retinitis pigmentosa
Ghanawi, H., & Koch, S. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101390 · Cited by 14
M-opsin protein degradation is inhibited by MG-132 in Rpe65⁻/⁻ retinal explant culture.
Sato, K., Ozaki, T., Ishiguro, S.-I., & Nakazawa, M. (2012) · PubMed Central · Cited by 18
S-opsin protein is incompletely modified during N-glycan processing in Rpe65−/− mice
Sato, K., Nakazawa, M., Takeuchi, K., Mizukoshi, S., & Ishiguro, S.-I. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.03.020 · Cited by 14
Sukseree, S., Chen, Y., Laggner, M., Грубер, Ф., Petit, V., Nagelreiter, I., Mlitz, V., Rossiter, H., Pollreisz, A., Schmidt-Erfurth, U. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161640 · Cited by 16
“Clinically, mutations in RPE65 are associated with type II Leber’s congenital amaurosis (LCA2), a hereditary retinal blinding disease caused by RPE65 deficiency [10].”
BackgroundVisual Cortex Plasticity Following Peripheral Damage To The Visual System: fMRI Evidence
Lemos, J., Pereira, D. J., & Castelo-Branco, M. S. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0691-0 · Cited by 16
Lutein and Zeaxanthin and Eye Disease
Vishwanathan, R., & Johnson, E. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-203-2_13 · Cited by 17
Identification of the Key Residues Determining the Product Specificity of Isomerohydrolase
Takahashi, Y., Moiseyev, G., Nikolaeva, O., & Ma, J.-X. (2012) · Biochemistry · doi:10.1021/bi300144n · Cited by 13
Remaining Rod Activity Mediates Visual Behavior in Adult Rpe65 −/− mice.
Cachafeiro, M. C. B., Bemelmans, A., Canola, K., Pignat, V., Crippa, S. V., Kostic, C., & Arsenijévic, Y. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3870 · Cited by 13
“Mutations in the Rpe65 gene are responsible for certain cases of Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP).(1,2) These diseases induce dramatic visual dysfunction starting in early childhood, although photoreceptors remain present in the retina for many years, and, depending on the mutation, devel…”
BackgroundMüller Cells and the Retinal Pigment Epithelium
Gullapalli, V. K., Sugino, I. K., & Zarbin, M. A. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50128-4 · Cited by 14
Chapter 11 Assessment of vision in infants and young children
Fulton, A. B., Hansen, R. M., & Moskowitz, A. (2005) · Handbook of clinical neurophysiology · doi:10.1016/s1567-4231(09)70208-4 · Cited by 13
Ozaki, T., Nakazawa, M., Kudo, T., Hirano, S., Suzuki, K., & Ishiguro, S.-I. (2014) · Current Eye Research · doi:10.3109/02713683.2014.907430 · Cited by 14
“Immunohistochemical analysis of the retina was performed as previously described.(11,34) After retinal”
Method9-cis Retinal Increased in Retina of RPE65 Knockout Mice with Decrease in Coat Pigmentation
Fan, J., Wu, B. X., Sarna, T., Rohrer, B., Redmond, T. M., & Crouch, R. K. (2006) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2006.tb09800.x · Cited by 13
Self-citationNakamura, H., Yamaki, K., Kondo, I., & Sakuragi, S. (2005) · Current Eye Research · doi:10.1080/02713680590968330 · Cited by 16
Summary of heritable ocular disorders and selected systemic conditions with eye findings
MacDonald, I. M., & Mah, D. (2000) · Ophthalmic Genetics · doi:10.1076/1381-6810(200003)2111-ift029 · Cited by 13
Clinical applications of retinal gene therapies
Fu, X., Huu, V. A. N., Duan, Y., Kermany, D., Valentim, C. C. S., Zhang, R., Zhu, J., Zhang, C. L., Sun, X., & Zhang, K. (2018) · Precision Clinical Medicine · doi:10.1093/pcmedi/pby004 · Cited by 13
Posterior Segment Approach for Subretinal Transplantation or Injection in the Canine Model
Verdugo, M. E., Alling, J., Lazar, E. S., del Cerro, M., Ray, J., & Aguirre, G. K. (2001) · Cell Transplantation · doi:10.3727/000000001783986710 · Cited by 12
Molecular genetics of infantile-onset retinal dystrophies
Moradi, P., & Moore, A. T. (2007) · Eye · doi:10.1038/sj.eye.6702843 · Cited by 14
What Is Next for Retinal Gene Therapy?
Vandenberghe, L. H. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017442 · Cited by 12
“RPE65, a gene encoding an enzyme pivotal in the recycling of the visual pigment chromophore 11-cis-retinal, was identified as one of the genes leading to LCA when mutated on both alleles (Marlhens et al. 1997).”
BackgroundVázquez-Domínguez, I., Duijkers, L., Fadaie, Z., Alaerds, E. C. W., Post, M. A., van Oosten, E., O’Gorman, L., Kwint, M. P., Koolen, L., Hoogendoorn, A. D. M., et al. (2022) · Cells · doi:10.3390/cells11223640 · Cited by 11
“2) gene was one of the first RPE-expressed genes discovered to be associated with retinal disease [7].”
BackgroundDewell, T. E., Gjoni, K., Liu, A. Z., Libby, A. R. G., Moore, A. T., So, P.-L., & Conklin, B. R. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102368 · Cited by 11
Yücel‐Yılmaz, D., Tarlan, B., Kıratlı, H., & Özgül, R. K. (2014) · DNA and Cell Biology · doi:10.1089/dna.2014.2554 · Cited by 12
“…3) (Friedman et al. , 2006), RDH12 (Retinol dehydrogenase 12) (Perrault et al. , 2004), RPE65 (Retinal pigment epithelium specific protein 65 kDa) (Marlhens et al. , 1997), RPGRIP1 (Retinitis pigmentosa GTPase regulator interacting protein 1) (Dryja et al. , 2001), SPATA7 (Sper-matogenesis…”
Use of human pluripotent stem cells to study and treat retinopathies
M’Barek, K. B. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i3.596 · Cited by 11
Down-regulation of RPE65 protein expression and promoter activity by retinoic acid.
Chen, Y., Ma, J.-X., & Crouch, R. K. (2003) · PubMed · Cited by 13
Sequence and structure of the mouse gene for RPE65.
Boulanger, A., Liu, S., Si, Y., & Redmond, T. M. (2001) · PubMed · Cited by 12
Self-citationInnovative gene delivery systems for retinal disease therapy
Wu, H., Dong, L., Jin, S., Zhao, Y.-W., & Zhu, L. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00797 · Cited by 12
“Mutations in the RPE65 gene are known to cause severe early-onset retinal dystrophy or LCA (Gu et al., 1997; Marlhens et al., 1997 This review primarily addresses the use of AAV vectors for targeted delivery to various retinal cell types.”
Wu, W., Takahashi, Y., Shin, H. Y., Ma, X., Moiseyev, G. P., & Ma, J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115202119 · Cited by 12
Complementation Test of Rpe65 Knockout and Tvrm148
Wright, C. B., Chrenek, M. A., Foster, S. L., Duncan, T. E., Redmond, T. M., Pardue, M. T., Boatright, J. H., & Nickerson, J. M. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12336 · Cited by 10
Self-citationSohocki, M. M., Browne, S. J., Sullivan, L. S., Blackshaw, S., Cepko, C. L., Payne, A. M., Bhattacharya, S. S., Khaliq, S., Mehdi, S. Q., Birch, D. G., et al. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00517-1 · Cited by 10
Bonilha, V. L., Rayborn, M. E., Li, Y., Grossman, G., Berson, E. L., & Hollyfield, J. G. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7973 · Cited by 12
“Typically, mutations in the RPE65 gene result in impaired vision from birth and typically progress to legal blindness in the third decade of life.(9,11,12,15,16) Mutations in RPE65 do not necessarily result in early loss of photoreceptors.”
BackgroundMack, H. G., Chen, F. K., Grigg, J., Jamieson, R. V., Roach, J. N. D., O’Hare, F., Britten‐Jones, A. C., McGuinness, M. B., Tindill, N., & Ayton, L. N. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048361 · Cited by 11
Genome editing: the breakthrough technology for inherited retinal disease?
Smith, A. J., Carter, S. P., & Kennedy, B. N. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1347629 · Cited by 11
Identification of Key Residues Determining Isomerohydrolase Activity of Human RPE65
Takahashi, Y., Moiseyev, G. P., & Ma, J.-X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.558619 · Cited by 10
Abduljaleel, Z. (2019) · Non-coding RNA Research · doi:10.1016/j.ncrna.2019.11.001 · Cited by 9
Lu, C., Li, S., & Jin, M. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.13.19 · Cited by 9
Parker, H. G., & Gilbert, S. F. (2015) · Advances in Genomics and Genetics · doi:10.2147/agg.s57678 · Cited by 10
The 2021 National Eye Institute Strategic Plan: Driving Innovation in Eye and Vision Research
Chiang, M. F. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.14.2 · Cited by 9
Photoreceptor function and structure in retinal degenerations caused by biallelic BEST1 mutations
Cideciyan, A. V., Jacobson, S. G., Sumaroka, A., Świder, M., Krishnan, A. K., Sheplock, R., Garafalo, A. V., Guziewicz, K. E., Aguirre, G. K., Beltran, W. A., et al. (2022) · Vision Research · doi:10.1016/j.visres.2022.108157 · Cited by 9
Hanein, S., Perrault, I., Gerber, S., Tanguy, G., Hamel, C., Dufier, J., Rozet, J., & Kaplan, J. (2005) · Journal Français d Ophtalmologie · doi:10.1016/s0181-5512(05)81031-9 · Cited by 11
“En effet, deux mutations hétérozygotes composites du gène RPE65 , précédemment localisé sur le chromosome 1p31, sont retrouvées chez deux germains atteints d’ACL [12, 13].”
BackgroundSelf-citationChebil, A., Falfoul, Y., Habibi, I., Munier, F. L., Schorderet, D. F., & Matri, L. E. (2016) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2015.08.013 · Cited by 10
Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism
Anderson, A. J., Stephan, M. J., Walker, W. O., & Kelley, R. I. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980806)78:5<401::aid-ajmg1>3.0.co;2-o · Cited by 48
Retinoid dynamics in vision: from visual cycle biology to retina disease treatments
Swigris, J., Widjaja‐Adhi, M. A. K., & Golczak, M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108902 · Cited by 8
Mayer, A.-K., Mahajnah, M. M., Zobor, D., von Bonin, M., Sharkia, R. A., & Wissinger, B. (2015) · PubMed Central · Cited by 10
Lorenz, B., Tavares, J., van den Born, L. I., Marques, J. P., Pilotto, E., Štingl, K., Issa, P. C., Leroux, D., Dollfus, H., & Scholl, H. P. N. (2023) · Ophthalmic Research · doi:10.1159/000529777 · Cited by 9
AIPL1 implicated in the pathogenesis of two cases of autosomal recessive retinal degeneration.
Li, D., Jin, C., Jiao, X., Li, L., Bushra, T., Naeem, M. A., Butt, N. H., Husnaın, T., Sieving, P. A., Riazuddin, S., et al. (2014) · PubMed Central · Cited by 9
Exclusion of LCA5 locus in a consanguineous Turkish family with macular coloboma-type LCA
Özgül, R. K., Bozkurt, B., Kıratlı, H., & Öğüş, A. (2005) · Eye · doi:10.1038/sj.eye.6702024 · Cited by 9
Perusek, L., Maeda, A., & Maeda, T. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2330-4_22 · Cited by 8
Dong, Y., Cai, X., Wu, Y., Liu, Y., Deng, L., & Chen, H. (2017) · PubMed · Cited by 8
RPE65 and the Accumulation of Retinyl Esters in Mouse Retinal Pigment Epithelium
Sheridan, C., Boyer, N. P., Crouch, R. K., & Koutalos, Y. (2017) · Photochemistry and Photobiology · doi:10.1111/php.12738 · Cited by 9
Artero‐Castro, A., Popelka, Š., Jendelová, P., Motlík, J., Ardan, T., Jimenez, F. J. R., & Erceg, S. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1559148 · Cited by 8
“Mutations in some of the RPE genes involved in the visual cycle such as RPE65, lecithin:retinol acyltransferase (LRAT), Cellular retinaldehyde-binding protein (CRALBP) and retinol dehydrogenase (RDH) usually lead to a mild retinal dystrophy such as retinitis pigmentosa (RP) [1,7] or severe and congenital retinal dystr…”
BackgroundAssessment of rAAV-Mediated Gene Therapy in the Rpe65-/- Mouse
Rakoczy, P. E., Lai, C., Yu, M. J. T., Daniels, D. M., Brankov, M., Rae, B. C., Stoddart, C. W., Barnett, N. L., Martin-Iverson, M. T., Redmond, T. M., et al. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0067-4_55 · Cited by 8
Self-citationThe role of vitamin A in visual transduction
Crouch, R. K., & Ma, J. (2000) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8454-9_5 · Cited by 10
“Mutations in the protein have been shown to result in at least two forms of early-onset retinal dystrophies in humans [ 73-75 ] and congenital stationary night blindness in the dog [76].”
BackgroundNovel mutations in RPE65 identified in consanguineous Pakistani families with retinal dystrophy.
Kabir, F., Naz, S., Riazuddin, S., Naeem, M. A., Khan, S. N., Husnaın, T., Akram, J., Sieving, P. A., Hejtmancik, J. F., & Riazuddin, S. (2013) · PubMed Central · Cited by 8
Wen, Y., & Birch, D. G. (2015) · Translational Vision Science & Technology · doi:10.1167/tvst.4.5.8 · Cited by 7
Fan, J., Crouch, R. K., & Kono, M. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6437 · Cited by 9
RPE65 takes on another role in the vertebrate retina
Redmond, T. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715064114 · Cited by 7
Self-citationDifferential neuroglycan C expression during retinal degeneration in Rpe65-/- mice.
Escher, P., Cottet, S., Aono, S., Oohira, A., & Schorderet, D. F. (2008) · PubMed Central · Cited by 9
Clinical and Molecular Genetic Aspects of Leber’s Congenital Amaurosis
Henderson, R., Lorenz, B., & Moore, A. T. (2006) · Springer eBooks · doi:10.1007/3-540-31220-x_10 · Cited by 7
Molecular Genetics of Retinal Disease
Brown, J., Webster, A. R., Sheffield, V. C., & Stone, E. M. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02598-0.50022-7 · Cited by 7
Chapter 45 Retinal disease in vertebrates
Brockerhoff, S. E. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)31049-x · Cited by 7
Zhang, M., Xiong, J., Yang, Z., Zhu, B., Wu, Y., Chen, X., & Wu, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115592 · Cited by 9
“The mutations that occur in this gene have been verified in some vertebrates, demonstrating their potential to influence the efficiency of carotenoid conversion and their content [20,21].”
BackgroundFujinami, K., Akiyama, K., Tsunoda, K., Ito, S., Seko, N., & Yamamoto, S. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.100876 · Cited by 7
Feathers, K. L., Jia, L., Khan, N. W., Smith, A. J., Ma, J., Ali, R. R., & Thompson, D. A. (2023) · Human Gene Therapy · doi:10.1089/hum.2022.240 · Cited by 6
Narfström, K. L., Tullis, G. E., & Seeliger, M. W. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-186-4_22 · Cited by 6
“system. However, like other internal structures in the eye, the subretinal space displays two important immune privilege features: (1) it will tolerate tissue grafts without immune rejection, and ( 2 ) it promotes the acquisition of systemic immune deviation to antigens placed within it (25).”
BackgroundBinding of rhodopsin and rhodopsin analogues to transducin, rhodopsin kinase and arrestin-1
Araujo, N. A., Sanz-Rodríguez, C. E., & Bubis, J. J. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.254 · Cited by 7
Marcos, I., Ruiz, A., Borrego, S., Ayuso, C., Baiget, M., & Antiñolo, G. (2001) · Medicina Clínica · doi:10.1016/s0025-7753(01)72038-6 · Cited by 6
Postnikova, O. A., Poliakov, E., Golestaneh, N., Rogozin, I. B., & Redmond, T. M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00634 · Cited by 5
“Human RPE65 mutations cause a spectrum of retinal dystrophies that result in blindness (RP20, LCA2) (Marlhens et al., 1997; Morimura et al., 1998).”
Self-citationEntrainment of circadian rhythm to a photoperiod reversal shows retinal dystrophy in RPE65−/− mice
Daniels, D. M., Stoddart, C. W., Martin-Iverson, M. T., LAI, C., Redmond, T. M., & Rakoczy, P. E. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00202-6 · Cited by 6
Self-citationBessant, D. A. R., Payne, A. M., SNOW, B. E., Antiñolo, G., MEHDI, S. Q., Bird, A. C., Siderovski, D. P., & Bhattacharya, S. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.5.384 · Cited by 6
ERK1/2 pathway is activated in degenerated Rpe65-deficient mice
Métrailler, S., Emery, M., Schorderet, D. F., Cottet, S., & Roduit, R. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.08.015 · Cited by 5
“Pathogenesis in the Rpe65 / mouse model of LCA is characterized by slow, progressive degeneration of the rod photoreceptors (Marlhens et al., 1997).”
BackgroundHiga, N., Hayashi, T., Mizobuchi, K., Iwasa, M., Kubota, S., Kuniyoshi, K., Kameya, S., Kondo, H., Kondo, M., & Nakano, T. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1442107 · Cited by 5
“Biallelic pathogenic variants in RPE65 were first identified in LCA/ EOSRD patients in 1997 (3, 4).”
BackgroundEyes shut homolog (EYS): Connecting molecule to disease
Marques, J. P., Sousa, I. S., Patrício, D., Simões, B. F., Chukwunalu, O., Zeitz, C., Audo, I. S., Collin, R. W. J., Quinn, P. M. J., Ambrósio, A. F., et al. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101391 · Cited by 6
RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals
Vooren, E. V., den Broeck, F. V., Mahieu, Q., Geens, E., Heetvelde, M. V., Bruyne, M. D., de Sompele, S. V., Uppal, S., Poliakov, E., Dhaenens, C., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.12.53 · Cited by 6
“Overall, this differs from the severe RCD associated with AR RPE65 - IRD 8,44,45 and the p.(D477G)-IRD that was initially described as an adult-onset choroideremia-like IRD with reduced or non-penetrance.”
Self-citationGenes and Mechanisms in Human Ciliopathies
Jenkins, D., & Beales, P. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00174-9 · Cited by 5
Gene Therapy for Retinitis Pigmentosa
Tomita, H., Sugano, E., Isago, H., Murayama, N., & Tamai, M. (2013) · InTech eBooks · doi:10.5772/52987 · Cited by 5
“Thus, in the case of LCA2, the cause of the disease is clearly identified as the biochemical blockade of the visual cycle caused by RPE65 deficiency [11,12].”
BackgroundNILSSON, S. E. G. (2006) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2006.00751.x · Cited by 9
The Consequences of Hypomorphic RPE65 for Rod and Cone Photoreceptors
Samardzija, M., Barben, M., Geiger, P., & Grimm, C. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_45 · Cited by 5
Modeling Retinal Diseases Using Genetic Approaches in Mice
Maeda, A., & Maeda, T. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7720-8_3 · Cited by 6
Cleavage of β-Carotene to Retinal
Wyss, A., & Lintig, J. V. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7499-0_16 · Cited by 9
Bernal, S., Calaf, M., Adán, A., Solans, T. T., Valverde, D., Ayuso, C., & Baiget, M. (2001) · Ophthalmic Genetics · doi:10.1076/opge.22.1.19.2237 · Cited by 5
GRIPT: a novel case-control analysis method for Mendelian disease gene discovery
Wang, J., Zhao, L., Wang, X., Chen, Y., Xu, M., Soens, Z. T., Ge, Z., Wang, P. R., Wang, F., & Chen, R. (2018) · Genome biology · doi:10.1186/s13059-018-1579-x · Cited by 5
Retroviral cDNA transfer to the RPE: stable expression and modification of metabolism.
Ray, J., Wolfe, J. H. N., Aguirre, G. K., & Haskins, M. E. (1998) · PubMed · Cited by 5
The Winston Churchill Memorial Trust of Australia Report by
Simpkin, T. (2005) · Cited by 5
Liu, F., Li, Q., Yang, Y., & Lü, F. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118423 · Cited by 4
Theoretical Study of the Photoisomerization Mechanism of All-Trans-Retinyl Acetate
Kochman, M. A., Palczewski, K., & Kubas, A. (2021) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.1c05533 · Cited by 4
Park, S. A., Rhodes, J., Iwabe, S., Ying, G., Pan, W., Huang, J., & Komáromy, A. M. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109106 · Cited by 5
Relatively preserved retinal function in RPE65-associated retinopathy: a case report
Mizobuchi, K., Hayashi, T., Kameya, S., Ohta, Y., Kuribayashi, K., & Shinoda, K. (2025) · Documenta Ophthalmologica · doi:10.1007/s10633-025-10007-4 · Cited by 4
“Biallelic pathogenic RPE65 variants are initially reported as a cause of Leber congenital amaurosis (LCA) [3, 4].”
Bennett, J. (2014) · Human Gene Therapy · doi:10.1089/hum.2014.2529 · Cited by 5
“This gene had recently been discovered as the cause of a large fraction of cases of congenital blindness (Gu et al., 1997; Marlhens et al., 1997; Morimura et al., 1998).”
Chang, B. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3661-8_21 · Cited by 4
Giers, B. C., Klein, D., Mendes-Madeira, A., Isiegas, C., Lorenz, B., Haverkamp, S., & Stieger, K. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00059 · Cited by 4
“Mutations in the RPE65 gene are associated with Leber’s congenital amaurosis type 2 or early onset severe retinal dystrophy, depending on the age of onset of severe visual impairment, which may vary widely in affected individuals (2, 7).”
BackgroundStockman, A., Henning, G. B., & Rider, A. T. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100937 · Cited by 4
“RPE65 The next example is of five patients suffering from Leber’s congenital amaurosis (LCA2), which is caused by mutations in RPE65 (see D in Figure 1), a gene that encodes an isomerase that is a key component of the visual cycle (e.g., Gu et al., 1997; Marlhens et al., 1997; Perrault et al., 1999b; Redmond et al., 1…”
Background
Metadata
- Authors
- Marlhens, F., Bareil, C., Griffoin, J.-M., Zrenner, E., Amalric, P., Eliaou, C., Liu, S.-Y., Harris, E., Redmond, T. M., Arnaud, B., Claustres, M., & Hamel, C. P.
- Affiliations
- Inserm (FR)
- University of Tübingen (DE)
- Hôpital Gui de Chauliac (FR)
- National Institutes of Health (US)
- Venue
- Nature Genetics
- Published
- 1997-10
- Volume
- 17
- Issue
- 2
- Pages
- 139-141
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1983421509
- Cited by
- 606
- References
- 10
- Citations by year
- 2026: 2 · 2025: 17 · 2024: 6 · 2023: 5 · 2022: 11 · 2021: 20 · 2020: 19 · 2019: 13 · 2018: 13 · 2017: 16 · 2016: 21 · 2015: 24 · 2014: 28 · 2013: 25 · 2012: 19
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- RPE65, Leber congenital amaurosis, genetic mutations, retinal degeneration, genetic spectrum, retinal dystrophy, visual cycle, S-palmitoylation, retinitis pigmentosa
- MeSH terms
- Retinoid Isomerohydrolase, Adolescent, Adult, Base Sequence, Blindness, Carrier Proteins, DNA, DNA Mutational Analysis, Eye Proteins, Female, Humans, Male, Mutation, Pedigree, Proteins, Optic Atrophies, Hereditary, Polymerase Chain Reaction, DNA Primers, cis-trans-Isomerases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.